Expert insights, guides, and stories about health 
The burgeoning landscape of AI in healthcare presents a critical juncture for health plans and investors alike. While the promise of AI to revolutionize care…
The recent implosion of Pear Therapeutics, once a darling of the digital therapeutics (DTx) space, serves as a stark, cautionary tale for investors and health…
The cautionary tale of Pear Therapeutics, once a darling of the digital therapeutics (DTx) space, serves as a stark reminder for investors and health plan…
The promise of artificial intelligence in healthcare has long captivated innovators and investors, but for health plan executives and employers, the critical question remains: how…
The promise of artificial intelligence in health is vast, yet its true value in a value-based care (VBC) framework hinges entirely on demonstrable, quantifiable outcomes.…
In the burgeoning landscape of AI-driven health solutions, a critical question looms for employers and health plan executives: how can we confidently invest in tools…
The promise of artificial intelligence in healthcare is vast, from optimizing operational efficiencies to revolutionizing patient care pathways. Yet, for employers and health plan executives…
The promise of artificial intelligence in healthcare is vast, offering unprecedented opportunities for efficiency gains, improved diagnostics, and personalized interventions. Yet, for employers and health…
The promise of artificial intelligence in healthcare is undeniable, offering pathways to improved outcomes and reduced costs. However, for health plans and employers navigating the…
The burgeoning landscape of AI in healthcare presents a critical divide for health plans and employers: distinguishing between solutions genuinely poised for value-based care (VBC)…
The promise of artificial intelligence in healthcare often conjures visions of advanced diagnostics and personalized treatment plans. Yet, for health plan executives and investors navigating…
The relentless pressure on health plans to manage their Medical Loss Ratios (MLR) has intensified, particularly with the escalating costs associated with cardiovascular disease. For…
The stark reality of healthcare economics is that a mere 5% of patients drive 50% of total spending. For investors, this concentration of cost represents…
Preventive cardiology is rapidly transforming from a clinical ideal into a significant economic driver for self-insured employers and risk-bearing providers. The confluence of rising healthcare…
The financial burden of avoidable cardiac emergency room visits represents a massive drain on healthcare systems, costing billions annually and severely impacting patient quality of…
The promise of artificial intelligence in healthcare has long been tempered by a critical investor question: beyond the technological marvel, where is the demonstrable return…
The promise of artificial intelligence in healthcare is vast, offering unprecedented opportunities to enhance diagnostics, personalize treatments, and optimize operational efficiencies. However, for AI health…
For self-insured employers and payers, the financial return on digital health investments hinges on preventing high-cost cardiovascular events before they occur. The transition to value-based…
The promise of artificial intelligence in healthcare is vast, yet its integration into value-based care (VBC) arrangements hinges on a critical, often overlooked, factor: demonstrable,…
The Centers for Medicare & Medicare Services (CMS) is relentlessly pushing healthcare providers towards value-based care (VBC) models, a shift that is profoundly reshaping the…
